Live Breaking News & Updates on Glucose cotransporter

Stay informed with the latest breaking news from Glucose cotransporter on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Glucose cotransporter and stay connected to the pulse of your community

Diabetes Drug Can Cut Risk of Kidney Stones

Discover the potential of SGLT2 inhibitors- a class of diabetes drugs, in mitigating kidney stones risk in diabetic patients.

Massachusetts , United-states , Julie-paik , Division-of-pharmacoepidemiology , Division-of-renal-kidney-medicine-at-brigham , Mass-general-brigham , Glucose-cotransporter , Nephrolithiasis-risk , Patients-with-type , Patients-rates , Massachusetts-general-hospital , Diabetes-drug

Diabetes medication class tied to lower risk

<p>Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones. In a study led by investigators from <a href="https://www.massgeneralbrigham.org/" target="_blank">Mass General Brigham</a>, researchers found that there was an association between the use of sodium-glucose contratransporter 2 (SGLT2) inhibitors and a lower risk of developing kidney stones. Their findings are reported in <a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2814491?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jamainternmed.2023.7660" target="_blank">JAMA Internal Medicine</a>. </p>

United-states , Massachusetts , Garyc-curhan , Julie-paik , Helen-tesfaye , Deborahj-wexler , Heidi-zakoul , Method-of-research , Drug-administration , Outcomes-research-institute , Division-of-renal-kidney-medicine-at-brigham , National-institute-of-aging

Diabetes Drug Class Linked to Reduced Kidney Stones Risk

Diabetes Drug Class Linked to Reduced Kidney Stones Risk
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Julie-paik , Helen-tesfaye , Garyc-curhan , Heidi-zakoul , Deborahj-wexler , National-institute-of-arthritis , Boehringer-ingelheim , National-institute-of-aging , Glaxosmithkline , Division-of-pharmacoepidemiology

SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes

Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes.

Julie-paik , Ibm , Us-centers-for-disease , Centers-for-disease , Harvard-medical-school , Women-hospital-harvard-medical-school-julie-paik , Disease-control , Clinformatics-data-mart-database , Medicare-fee-for-service-parts , Glucose-cotransporter , Nephrolithiasis-risk , Patients-with-type

Precision Diabetes, Inc.: A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence

Precision Diabetes, Inc.: A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

North-carolina , United-states , Japan , Raleigh , Australia , Mexico , American , Japanese , Elizabeith-selvin , Johns-hopkins , Aveon-health-scottsdale , Precision-diabetes-inc

A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence

A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

North-carolina , United-states , Japan , Mexico , Raleigh , Australia , Japanese , American , Johns-hopkins , Elizabeith-selvin , American-diabetes-association , Johns-hopkins-bloomberg-school-of-public-health

SGLT2 inhibitors have similar fracture risk as other antidiabetics in postmenopausal women with diabetes: JAMA

South Korea: A claims-based study involving two independent Korean cohorts revealed that SGLT2 inhibitors are associated with a lower or similar risk of fracture versus incretin-based antidiabetic...

South-korea , Suwon , Cheju-do , Hwa-yeon-ko , Sungkyunkwan-university , Glucose-cotransporter , Incretin-based-drugs , Jama-network-open , Glt2-inhibitors , Ncretin-based-drugs , Ype-2-diabetes , Racture

Mandrola's Top 10 Cardiology Stories of 2021

Obesity drugs had a good year, the SGLT2 inhibitors stalled, and Entresto looks less impressive -- these are some of the takes from John Mandrola, MD, in his annual review of cardiology research.

Sweden , United-states , Kentucky , John-mandrola , Jay-brophy , John-hampton , Gabriel-steg , Mcgill-university , Bad-news , Glucose-cotransporter , Less-impressive-year , Left-atrial-appendage-closure-shines